Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2020

01-12-2020 | Letter to the Editor

Comments: The Prognostic Index Independently Predicts Survival in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Resection

Authors: Qiqing Sun, MD, Yiyin Zhang, MD, Xiaowu Xu, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2020

Login to get access

Excerpt

We have read with great interest the study presented by Gruber et al.1 The authors used a prognostic index (PI) consisting of C-reactive protein (CRP) levels and white blood cell (WBC) counts for a cohort of patients with pancreatic ductal adenocarcinoma (PDAC) undergoing resection to predict survival and found that the PI is a reliable independent prognostic tool. We congratulate the authors of this valuable work and express some of our opinions. …
Literature
1.
2.
Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212–22.CrossRef
3.
4.
Jinkins LJ, Parmar AD, Han Y, et al. Current trends in preoperative biliary stenting in patients with pancreatic cancer. Surgery. 2013;154:179–89.CrossRef
5.
Ishizuka M, Nagata H, Takagi K, et al. Clinical significance of the C-reactive protein to albumin ratio for survival after surgery for colorectal cancer. Ann Surg Oncol. 2016;23:900–7.CrossRef
6.
Li H, Han D, Hou Y, et al. Statistical inference methods for two crossing survival curves: a comparison of methods. PLoS One 2015;10:e0116774.CrossRef
Metadata
Title
Comments: The Prognostic Index Independently Predicts Survival in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Resection
Authors
Qiqing Sun, MD
Yiyin Zhang, MD
Xiaowu Xu, MD
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08369-x

Other articles of this Special Issue 3/2020

Annals of Surgical Oncology 3/2020 Go to the issue

ASO Author Reflections

ASO Author Reflections: Most Patients Do Not Need Discharge Opioid Prescriptions After Lumpectomy or Excisional Biopsy Procedures

Pancreatic Tumors

Comments on “Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma”

ASO Author Reflections

ASO Author Reflections: The Difficult Assessment of the Hard-Won Progress of Breast Cancer Care

Correction

Correction to: Merkel Cell Carcinoma Outcomes: Does AJCC8 Underestimate Survival?

ASO Author Reflections

ASO Author Reflections: Use of Peritoneal Cancer Index (PCI) to Evaluate Carcinomatosis in Ovarian Cancer

ASO Author Reflections

ASO Author Reflections: Omission of Axillary Lymph Node Dissection for Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant Chemotherapy: Not Ready for Primetime?